home / stock / th:cc / th:cc quote
Last: | $2.90 |
---|---|
Change Percent: | 1.4% |
Open: | $2.86 |
Close: | $2.86 |
High: | $2.9 |
Low: | $2.86 |
Volume: | 3,724 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.9 | $2.86 | $2.86 | $2.9 | $2.86 | 3,724 | 08-02-2022 |
$3.22 | $3.04 | $3.22 | $3.22 | $3.01 | 17,414 | 05-06-2022 |
$3.13 | $3.24 | $3.13 | $3.26 | $3.06 | 15,277 | 05-05-2022 |
$3.22 | $3.31 | $3.22 | $3.31 | $3.2 | 16,876 | 05-04-2022 |
$3.3 | $2.96 | $3.3 | $3.4 | $2.96 | 86,908 | 05-03-2022 |
$3.175 | $3.08 | $3.175 | $3.175 | $2.66 | 198,003 | 05-02-2022 |
$3.02 | $2.95 | $3.02 | $3.06 | $2.91 | 32,816 | 04-29-2022 |
$2.96 | $3.15 | $2.96 | $3.15 | $2.88 | 28,035 | 04-28-2022 |
$3.12 | $3.25 | $3.12 | $3.25 | $3.11 | 29,856 | 04-27-2022 |
$3.26 | $3.3 | $3.26 | $3.35 | $3.25 | 43,246 | 04-26-2022 |
$3.26 | $3.22 | $3.26 | $3.35 | $3.15 | 35,856 | 04-25-2022 |
$3.17 | $3.11 | $3.17 | $3.33 | $3.1 | 29,393 | 04-22-2022 |
$3.18 | $3.3 | $3.18 | $3.36 | $3.14 | 28,558 | 04-21-2022 |
$3.37 | $3.36 | $3.37 | $3.37 | $3.29 | 5,836 | 04-20-2022 |
$3.33 | $3.33 | $3.33 | $3.33 | $3.26 | 10,638 | 04-19-2022 |
$3.33 | $3.35 | $3.33 | $3.4 | $3.26 | 12,085 | 04-18-2022 |
$3.37 | $3.22 | $3.37 | $3.39 | $3.17 | 53,767 | 04-15-2022 |
$3.37 | $3.22 | $3.37 | $3.39 | $3.17 | 53,567 | 04-14-2022 |
$3.22 | $3.21 | $3.22 | $3.3 | $3.17 | 46,716 | 04-13-2022 |
$3.2 | $3.02 | $3.2 | $3.2 | $3.02 | 16,945 | 04-12-2022 |
News, Short Squeeze, Breakout and More Instantly...
Theratechnologies Inc. Company Name:
TH:CC Stock Symbol:
TSXC Market:
First long-term data presentation from Parts 1 and 2 of the Phase 1 clinical trial of sudocetaxel zendusortide in solid tumors Part 3 of Phase 1 trial in advanced ovarian cancer is ongoing MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechno...
MONTREAL, April 15, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the Company h...
MONTREAL, April 11, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the Company...